Thus, although YAP/TAZ depletion has the potential to inhibit cancer stem cell expansion in a clinical setting[97], it is very likely that YAP/TAZ inhibition would also negatively affect essential stem cell pools in non-cancerous tissues. The gene discussed is YAP1; the disease is cancer.